862 results on '"Barad, David H."'
Search Results
2. Previously reported and here added cases demonstrate euploid pregnancies followed by PGT-A as “mosaic” as well as “aneuploid” designated embryos
3. A review of the 2021/2022 PGDIS Position Statement on the transfer of mosaic embryos
4. Changing clinical significance of oocyte maturity grades with advancing female age advances precision medicine in IVF
5. Optimal IVF Protocols for Women over 40 and Low Functional Ovarian Reserve
6. Importance of IGF-I levels in IVF: potential relevance for growth hormone (GH) supplementation
7. PGT-A “perfect” is the enemy of good
8. Predictive value of cytoplasmic granulation patterns during in vitro fertilization in metaphase II oocytes: Part I, poor-prognosis patients
9. Not even noninvasive cell-free DNA can rescue preimplantation genetic testing
10. Predictive value of cytoplasmic granulation patterns during in vitro fertilization in metaphase II oocytes: part II, donor oocyte cycles
11. A form of secondary ovarian insufficiency (SOI) due to adrenal hypoandrogenism as new infertility diagnosis
12. Depletion of aneuploid cells in human embryos and gastruloids
13. Time associations between U.S. birth rates and add-Ons to IVF practice between 2005–2016
14. Rate of rebound in follicle growth after cessation of ovarian stimulation in initial non‐responders: a prospective cohort study
15. Individualized Ovarian Stimulation in Patients with Advanced Maternal Age and Premature Ovarian Aging
16. U.S. UTILIZATION OF PGT-A ACCORDING TO CLINIC OWNERSHIP-PRIVATE, ACADEMIC/HOSPITAL/MILITARY, AND EQUITY VENTURE CAPITAL
17. Why is use of donor eggs not viewed as treatment failure? A call for improvements in treatments with autologous oocytes
18. Euploid miscarriage is associated with elevated serum C-reactive protein levels in infertile women: a pilot study
19. Worldwide live births following the transfer of chromosomally “Abnormal” embryos after PGT/A: results of a worldwide web-based survey
20. Author Correction: Depletion of aneuploid cells in human embryos and gastruloids
21. Effects of dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal infertile women
22. Contributors
23. The Ovarian Factor in Assisted Reproductive Technology
24. IVF outcomes in average- and poor-prognosis infertile women according to the number of embryos transferred
25. Age-Specific IVF Outcomes in Infertile Women With Baseline FSH Levels ≥20 mIU/mL
26. Suspected ontogeny of a recently described hypo-androgenic PCOS-like phenotype with advancing age
27. Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine
28. PGT-A “perfect” is the enemy of good
29. Preimplantation genetic testing for aneuploidies screening is not diagnostic
30. Early decline in functional ovarian reserve in young women with low (CGGn < 26) FMR1 gene alleles
31. Impact of preimplantation genetic screening on donor oocyte-recipient cycles in the United States
32. HOW INCREASING PGT-A UTILIZATION AFFECTS IVF CYCLE OUTCOMES IN U S IVF CENTERS
33. Redirecting reproductive immunology research toward pregnancy as a period of temporary immune tolerance
34. How FSH and AMH reflect probabilities of oocyte numbers in poor prognosis patients with small oocyte yields
35. The importance of redundancy of functional ovarian reserve when investigating potential genetic effects on ovarian function
36. Reconsidering the Polycystic Ovary Syndrome (PCOS)
37. Utilization of third-party in vitro fertilization in the United States
38. Letter to the Editor: Including the Zona Reticularis in the Definition of Hypoadrenalism and Hyperadrenalism
39. With low ovarian reserve, Highly Individualized Egg Retrieval (HIER) improves IVF results by avoiding premature luteinization
40. Age at menarche: a predictor of diminished ovarian function?
41. The status of public reporting of clinical outcomes in assisted reproductive technology
42. The impact of patient preselection on reported IVF outcomes
43. Rescue in vitro maturation (IVM) of immature oocytes in stimulated cycles in women with low functional ovarian reserve (LFOR)
44. Why Prospectively Randomized Clinical Trials Have Been Rare in Reproductive Medicine and Will Remain So?
45. We have reached a dead end for preimplantation genetic testing for aneuploidy
46. REPLY: More on the conversion of DHEA to testosterone
47. A case–control pilot study of low-intensity IVF in good-prognosis patients
48. The big freeze—hope for patients with adenomyosis?
49. Utility of age-specific serum anti-Müllerian hormone concentrations
50. A PILOT STUDY OF OOCYTE PRODUCTION AND ENDOCRINE RESPONSE AFTER INTRAOVARIAN TREATMENT WITH PLATELET-RICH PLASMA (PRP) IN INFERTILE WOMEN OF VERY ADVANCED AGE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.